StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences operating margin

Operating margin is operating income as a percentage of revenue.

ENDRA Life Sciences's operating margin for the twelve months ending Dec 31, 2018 was -146080.5%. For fiscal 2018 it was -146080.5%, against -1315.6% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2018Dec 31, 2018-146080.5%−144764.8
FY2017Dec 31, 2017-1315.6%−968.1
FY2016Dec 31, 2016-347.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2018Mar 31, 2018-45960.8%−45898.9
Q4 FY2017Dec 31, 2017-33526.6%–
Q3 FY2017Sep 30, 2017-317.4%–
Q2 FY2017Jun 30, 2017-1829.4%–
Q4 FY2016Dec 31, 2016-61.8%–

More ENDRA Life Sciences figures

See a number that looks wrong?